Stock JUNO THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Juno Therapeutics Inc

Equities

US48205A1097

Biotechnology & Medical Research

Managers

Managers TitleAgeSince
Nicole Keith IRC
 Investor Relations Contact - 15-06-30
Jonathan Biller TRE
 Treasurer 61 -
Katherine Reynolds Kelly SEC
 Corporate Secretary 48 -

Members of the board

Members of the board TitleAgeSince
Mark Alles BRD
 Director/Board Member 64 -
Peter Kellogg BRD
 Director/Board Member 67 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 116,105,371 90,604,961 ( 78.04 %) 0 78.04 %

Company contact information

Juno Therapeutics, Inc.

400 Dexter Avenue North Suite 1200

98109, Seattle

+206-582-1600

http://junotherapeutics.com
address Juno Therapeutics Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.26% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.41% 95.71B
ARGENX SE Stock argenx SE
+0.64% 22.02B
BIONTECH SE Stock BioNTech SE
-17.84% 20.9B
GENMAB A/S Stock Genmab A/S
-9.07% 17.85B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.83% 16.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-17.63% 15.52B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.55% 13.86B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+32.11% 12.04B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Juno Therapeutics Inc